You are here

  • Home
  • Archive
  • Volume 11, Issue 10
  • Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

 

Online download statistics by month:

Online download statistics by month: October 2023 to August 2025

AbstractFullPdf
Oct 2023860879263
Nov 2023414421114
Dec 202311211638
Jan 2024697538
Feb 202415916174
Mar 202416617187
Apr 202416817177
May 202412612963
Jun 2024255256103
Jul 202414614967
Aug 202412812850
Sep 202413813993
Oct 202424024276
Nov 202419820063
Dec 202418519149
Jan 202511311477
Feb 202516016163
Mar 2025929266
Apr 202513413456
May 202510910952
Jun 2025788033
Jul 2025110
Aug 2025110
Total405241201602